Weiss, S. & Bogen, B. MHC class II-restricted presentation of intracellular antigen. Cell 64, 767–776 (1991).

Article  PubMed  CAS  Google Scholar 

Axelrod, M. L., Cook, R. S., Johnson, D. B. & Balko, J. M. Biological consequences of MHC-II expression by tumor cells in cancer. Clin. Cancer Res. 25, 2392–2402 (2019).

Article  PubMed  CAS  Google Scholar 

Nanaware, P. P., Cruz, J., Khaja, M., Shaffer, S. A. & Stern, L. Inhibited MHC class I and MHC class II antigen processing and presentation upon SARS-CoV-2 infection. J. Immunol. 210, 222.02 (2023).

Gras, S. CD4+ T cell mediated HLA class II cross-restriction in HIV controllers. J. Immunol. 204, eaat0687 (2020).

Article  Google Scholar 

Zakharova, M. Y., Belyanina, T. A., Sokolov, A. V., Kiselev, I. S. & Mamedov, A. E. The contribution of major histocompatibility complex class II genes to an association with autoimmune diseases. Acta Naturae 11, 4–12 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Wieber, K., Zimmer, C. L. & Hertl, M. Detection of autoreactive CD4+ T cells by MHC class II multimers in HLA-linked human autoimmune diseases. J. Clin. Invest. 131, e148674 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Davies, C. S. et al. Immunogenetic variation shapes the gut microbiome in a natural vertebrate population. Microbiome 10, 41 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Wosen, J. E., Mukhopadhyay, D., Macaubas, C. & Mellins, E. D. Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts. Front. Immunol. 9, 2144 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Roche, P. A. & Furuta, K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat. Rev. Immunol. 15, 203–216 (2015).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pishesha, N., Harmand, T. J. & Ploegh, H. L. A guide to antigen processing and presentation. Nat. Rev. Immunol. 22, 751–764 (2022).

Article  PubMed  CAS  Google Scholar 

Stern, L. J. & Santambrogio, L. The melting pot of the MHC II peptidome. Curr. Opin. Immunol. 40, 70–77 (2016).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baulu, E., Gardet, C., Chuvin, N. & Depil, S. TCR-engineered T cell therapy in solid tumors: state of the art and perspectives. Sci. Adv. 9, eadf3700 (2023).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Weber, K. S., Donermeyer, D. L., Allen, P. M. & Kranz, D. M. Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function. Proc. Natl Acad. Sci. USA 102, 19033–19038 (2005).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li, Y., Jiang, W. & Mellins, E. D. TCR-like antibodies targeting autoantigen–MHC complexes: a mini-review. Front. Immunol. 13, 968432 (2022).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Poncette, L., Chen, X., Lorenz, F. K. & Blankenstein, T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J. Clin. Invest. 129, 324–335 (2019).

Article  PubMed  Google Scholar 

Spanier, J. A. et al. Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice. J. Clin. Invest. 133, e168601 (2023).

PubMed  PubMed Central  CAS  Google Scholar 

Hoydahl, L. S., Frick, R., Sandlie, I. & Loset, G. A. Targeting the MHC ligandome by use of TCR-like antibodies. Antibodies 8, 32 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wucherpfennig, K. W. & Strominger, J. L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695–705 (1995).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lunemann, J. D. et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2. J. Exp. Med. 205, 1763–1773 (2008).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jardetzky, T. S. et al. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl Acad. Sci. USA 93, 734–738 (1996).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hahn, M., Nicholson, M. J., Pyrdol, J. & Wucherpfennig, K. W. Unconventional topology of self peptide–major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6, 490–496 (2005).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beringer, D. X. et al. T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex. Nat. Immunol. 16, 1153–1161 (2015).

Article  PubMed  CAS  Google Scholar 

Cole, D. K. et al. Human TCR-binding affinity is governed by MHC class restriction. J. Immunol. 178, 5727–5734 (2007).

Article  PubMed  CAS  Google Scholar 

Hennecke, J., Carfi, A. & Wiley, D. C. Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 19, 5611–5624 (2000).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hennecke, J. & Wiley, D. C. Structure of a complex of the human α/β T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195, 571–581 (2002).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Broughton, S. E. et al. Biased T cell receptor usage directed against human leukocyte antigen DQ8-restricted gliadin peptides is associated with celiac disease. Immunity 37, 611–621 (2012).

Article  PubMed  CAS  Google Scholar 

Frick, R. et al. A high-affinity human TCR-like antibody detects celiac disease gluten peptide–MHC complexes and inhibits T cell activation. Sci. Immunol. 6, eabg4925 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hülsmeyer, M. et al. A major histocompatibility complex–peptide-restricted antibody and T cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1–MAGE-A1 in complex with Fab-Hyb3. J. Biol. Chem. 280, 2972–2980 (2005).

Article  PubMed  Google Scholar 

Ataie, N. et al. Structure of a TCR-mimic antibody with target predicts pharmacogenetics. J. Mol. Biol. 428, 194–205 (2016).

Article  PubMed  CAS  Google Scholar 

Starwalt, S. E., Masteller, E. L., Bluestone, J. A. & Kranz, D. M. Directed evolution of a single-chain class II MHC product by yeast display. Protein Eng. 16, 147–156 (2003).

Article  PubMed  CAS  Google Scholar 

Dahan, R. & Reiter, Y. T-cell-receptor-like antibodies—generation, function and applications. Expert Rev. Mol. Med. 14, e6 (2012).

Article